Without approved treatments or vaccines to prevent Sudan Ebolavirus outbreaks in 2025, the World Health Organization (WHO) and its partners have immediately supported the Republic of Uganda's response to a potential new outbreak by facilitating access to a candidate vaccine.
As of January 31, 2025, the first 2,160 doses of IAVI's rVSV Sudan ebolavirus vaccine candidate (IAVI C108, rVSVΔG-SUDV-GP) were in Uganda's capital, Kampala, where they were prepositioned as part of outbreak preparedness.
Read More
